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Abstract
Background: The development of COVID-19 pandemic has
affected all segments of the population; however, it had a signifi-
cant impact on vulnerable subjects, such as in people experiencing
homelessness. The aim of this study was to evaluate the preva-
lence of COVID-19 spread in homeless persons in the city of
Rome, Italy.  
Design and Methods: Patients included in the study underwent
a clinical evaluation and rapid antibody analysis on capillary
blood for the presence of immunoglobulin G (IgG) and
immunoglobulin M (IgM) antibodies to SARS-CoV-2 virus.
Symptomatic patients were not included in the screening and
immediately referred to local hospitals for further evaluation. 
Results: One-hundred seventy-three patients of both sexes
were tested for SARS-CoV-2 infection through rapid serological
test. Age range was 10-80 years; people came from 35 different
countries of origin and 4 continents. Test results were negative for
most patients (170-98.2%); two patients had positive IgM (1.2%)
and one patient had positive IgG (0.6%).
Conclusions: Our study is the first to evaluate the prevalence
of SARS-CoV-2 infection in people experiencing homelessness in
the city of Rome, Italy. Most patients were negative for COVID-
19, although several factors may have had an impact on this result,
such as the exclusion of symptomatic patients, the limited sensi-
tivity of rapid serological tests in the initial stage of infection and
the prevention measures adopted in these populations. Larger
studies on fragile populations are needed to prevent and intercept
new clusters of infection in the upcoming months.
Introduction
The development of the recent Coronavirus Disease 19
(COVID-19) pandemic due to the Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2) has affected all seg-
ments of the population transversely; however, the infection had a
significantly worse impact on vulnerable subjects, such as home-
less persons.1-4
In these specific populations the presence of the SARS-CoV-
2 virus is rarely known, and it is possible to imagine them as hid-
den sources of contagion that may be difficult to trace through epi-
demiological link studies.5-12 Furthermore, people experiencing
homelessness live in congregate settings that may favor contagion
and infection spread, as they share common spaces often without
adequate social distancing, individual protections such as face
masks may be unavailable or incorrectly worn, and in some cases,
they may not fully understand rules and means of contagion as
they are not correctly and routinely informed. In addition, previ-
ous research has shown that homeless persons may have physical
and mental diseases that cause a mortality several times higher
than the general population, and COVID-19 might further worsen
this disparity.13,14
The aim of this preliminary study was to evaluate through
rapid serology-based testing the prevalence of SARS-CoV-2
infection in the homeless population in the city of Rome, Italy.
Significance for public health
The development of COVID-19 pandemic has affected all segments of the population; however, it had a significant impact on vulnerable subjects, such as the
homeless population. People experiencing homelessness live in environments that may favor contagion and infection spread; the presence of the SARS-CoV-2
among them is rarely known, and it is possible to imagine them as hidden sources of contagion that may be difficult to trace through epidemiological link stud-
ies. Furthermore, people experiencing homelessness have an all-cause mortality higher than the general population, and COVID-19 might further increase this
disparity. A more detailed understanding of the characteristics and spread of SARS-CoV-2 infection among the homeless population is of utmost importance to
develop public health interventions in these communities and to prevent and intercept new clusters of infection.
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The study was performed between April and July 2020 in
homeless persons in the city of Rome, Italy, referring to two pri-
mary care services dedicated to fragile patients. The first is the
Madre di Misericordia Primary Care Service of the Eleemosynaria
Apostolica and its mobile healthcare facilities located in the
Vatican City State serving a large cohort of fragile patients in the
surrounding areas; the second is the Medicina Solidale primary
care service, located in a suburban area of the city of Rome, Italy.
At admission, patients were screened for symptoms suggestive
of COVID-19, such as fever >37.5°C, cough, tiredness, sore throat
and breathing difficulties at the time of the admission and in the 14
days before; if positive to one of these, patients were not admitted
to the service and referred to local hospitals for further evaluation.
For each patient, an internal medicine physician compiled a
clinical-anamnestic record including personal data, lifestyles and
living conditions, performed a basic health assessment with med-
ical examination and vital signs measurement (body temperature
measurement, blood pressure measurement, oxygen saturation
measurement), and executed a rapid antibody analysis on capillary
whole blood samples from the fingertip for the presence of specific
antibodies, immunoglobulin G (IgG) and immunoglobulin M
(IgM), to SARS-CoV-2 virus (Biozek Medical COVID-19 Rapid
Test, Inzek B.V., Apeldoorn, the Netherlands). In addition, face
masks, gloves, hand hygienizing gels were distributed to patients.
The study was conducted in accordance with the Declaration
of Helsinki; all patients signed a written informed consent to per-
form the rapid serological test and participate to the study.
Results
One-hundred seventy-three patients were tested for COVID-19
through rapid serology-based tests between April 14 and July 31,
2020 in two primary care services in the city of Rome, Italy. 
Average age was 45.6 years (age range: 10-80 years). Age dis-
tribution is shown in Figure 1A; the most common age groups
were 41-50 and 51-60 years (45 and 50 patients, respectively), fol-
lowed by 21-30, 31-40 and 61-70 years (28, 20 and 17 patients,
respectively). The least numerous groups were 0-10, 11-20 and 71-
80 years (1, 7 and 5 patients, respectively). The sample included
122 males (70.5%) and 51 females (29.5%) (Figure 1B).
Patients had 35 different countries of origin in four continents;
the most represented countries were Italy (43.3%), Poland (9.2%)
and Romania (7.5%). Details are shown in Figure 2. Continent of
origin was Europe for 114 patients (65.9%), followed by Africa (29
patients, 16.8%), North and South America (18 patients, 10.4%)
and Asia (12 patients, 6.9%). Caucasians were the most represent-
ed in our sample.
Test results were negative for most patients (170-98.2%); two
patients had positive IgM (1.2%) and one patient had positive IgG
(0.6%). (Figure 3). The patients with a positive IgG or IgM test
were immediately referred to the local hospital for further evalua-
tion and for the activation of the recommended public health pro-
tocols. 
Discussion
We investigated the prevalence of COVID-19 in a fragile pop-
ulation consisting of homeless persons in the city of Rome, Italy.
Fragile populations have specific peculiarities in regard to virus
transmission and disease status compared to the general popula-
tion.8 These populations usually live in settings that favor infection
spread, such as shelters, encampments or abandoned buildings,4
and may not have regular access to basic hygiene supplies or show-
ering facilities,1-3,5,6,11,13-16 thus leading to potential outbreaks as
those reported in the past months by several authors.12,17-19 In addi-
tion, these persons might be more geographically mobile than the
general population,1,4 making it difficult to track and prevent infec-
tion transmission.1,16 Furthermore, many homeless persons have
chronic or acute comorbidities such as mental and physical condi-
tions,20 may engage in substance abuse,21 and have limited access
to health care structures;9,22 this may worsen the impact of
COVID-19 symptoms in these patients leading to a higher rate of
SARS-CoV-2 morbidity and mortality.5-12
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Figure 1. Age (A) and sex (B) distribution in our sample. 
Figure 2. Details of country of origin for patients included in our
study
Figure 3. Rapid serology-based test results in our sample. Tests
were negative for most patients (170-98.2%); two patients had
positive IgM (1.2%) and one patient had positive IgG (0.6%).










Age and sex distribution in our sample included patients of
both sexes ranging from 10 and 80 years of age. Although the more
represented group was that of adult males, our sample also com-
prised children and elderly subjects, thus including all tiers of the
population. 
The large number of different countries of origin of our
patients also allowed a good geographical representation of the tar-
get population. In fact, our group included people from 35 different
countries in four continents. The most represented countries were
Italy and other European countries, such as Poland and Romania;
these countries reflect a significant portion of the homeless popu-
lation in Rome.23,24 The number of African-origin people in our
sample also confirm a good penetration among people with immi-
grant status that experience homeless condition, which in Italy is in
part represented by Africans.25-27
Our data showed only two IgM positive cases and one positive
IgG case among the investigated subjects. These findings may be
explained by several factors. The first is that the target population
was screened for symptoms suggestive of COVID-19, such as
fever >37.5°C, cough, tiredness, sore throat and breathing difficul-
ties at the time of admission or in the previous 14 days and, if pos-
itive to one of these, patients were not admitted to the service and
referred to local hospitals for further evaluation. This may have
prevented people with active SARS-CoV-2 infection to be includ-
ed in the screening. Secondly, although rapid serological COVID-
19 tests have several advantages such as the easiness to perform
and fast response, they may have a limited sensitivity, especially in
the early phase of infection before seroconversion; this suggests
that negative results at these tests may be unreliable to exclude
recent cases of SARS-CoV-2 infection where a rapid antigen test
or PCR nasopharyngeal swab would be more appropriate.
Comparative studies that evaluated the rapid serological COVID-
19 tests sensitivity and specificity showed a sensitivity ranging
from 30% to 96% and a specificity ranging from 96% to 98%.28-32
A Cochrane Review on 54 studies28 showed that rapid serological
tests for the combination of IgG/IgM had a sensitivity of 30.1% in
the period of 1 to 7 days, 72.2% 8 to 14 days, 91.4% 15 to 21 days,
and 96% 21 to 35 days after symptom onset. This suggests that the
sensitivity of rapid serological tests can be low in patients suspect-
ed for COVID-19 in the early period but improves in patients with
at least 7 days of symptoms indicating a higher reliability for
detecting previous infection if used >15 days after the onset of
symptoms.28-32 In our population, this may have resulted in some
false negative cases, while symptomatic patients that may have
resulted positive were not included in the screening. For all these
reasons, and for the recent introduction of rapid antigen tests, it is
important to associate to serological antibody analysis a rapid anti-
gen or PCR nasopharyngeal swab to identify cases in the early
days of infection and avoid missing positive cases, especially if
asymptomatic.
Last, but not less important, the target populations were previ-
ously educated to methods and best practices to prevent infection
spread. Furthermore, face masks and hand hygienizing gels were
distributed to these populations; these actions may have con-
tributed to the prevention of infection spread and to limit the num-
ber of patients with previous infection (positive IgG).33
This study has several limits. The first is the small number of
patients evaluated that may have limited the exact representation
of virus diffusion among the target population. Furthermore, men-
tal and physical comorbidities have not been investigated.
Secondly, the exclusion from the screening of symptomatic
patients may have affected the number of positive patients found.
The third is that this study relied exclusively on rapid serological
tests, while additional screening tests such as rapid antigen or PCR
testing from nasopharyngeal swabs and antibody testing for the
qualitative detection of antibodies against SARS-CoV-2 in the
blood were not used and would have been more indicative of infec-
tion especially in the initial phase of the infection and in asympto-
matic patients
In conclusion, our study is the first to report data on people
experiencing homelessness in the city of Rome, Italy. Additional
studies to evaluate the prevalence of COVID-19 infection in frag-
ile populations, including more testing methods such as nasopha-
ryngeal swab or quantitative analysis on peripheral blood, as well
as symptomatic patients, are needed to evaluate the effectiveness
of public health interventions against the spread of COVID-19 in
these communities and to prevent and intercept new clusters of
infection in the upcoming months.
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